Kiora Pharmaceuticals, Inc.
Kiora Pharmaceuticals, Inc. (KPRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KPRX · as of Jun 9, 2026
Key Statistics
Explore Kiora Pharmaceuticals, Inc. Data
kprx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
Competitors & Peers
kprx competitorsKPRX
ACXP
ADIL
APRE
APVO
BCDAStock Performance
Full HistoryAbout Kiora Pharmaceuticals, Inc.
Kiora Pharmaceuticals, Inc. a specialty pharmaceutical firm operating at the clinical stage, is dedicated to the creation and commercialization of treatments for various ophthalmic conditions across …
what is kiora pharmaceuticals, inc. · kprx stock overview · kiora pharmaceuticals, inc. company profile · who is kiora pharmaceuticals, inc. ceo · kprx NASDAQ · kiora pharmaceuticals, inc. headquarters · kiora pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Kiora Pharmaceuticals, Inc. (KPRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 13, 2015. As of the latest trading session, KPRX stock price is $2.58, with a market capitalization of $11.4M. The stock has returned -20.62% over the past 12 months and +30.96% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Kiora Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Kiora Pharmaceuticals, Inc. reported revenue of — and net income of -$10.8M. For detailed data — including Kiora Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Kiora Pharmaceuticals, Inc. (KPRX) stock price is $2.58. The stock is traded on NASDAQ under the ticker symbol KPRX. The 52-week range is $1.76 – $3.39.